<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="iid3825" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Immun Inflamm Dis</journal-id><journal-id journal-id-type="iso-abbrev">Immun Inflamm Dis</journal-id><journal-id journal-id-type="pmc-domain-id">2617</journal-id><journal-id journal-id-type="pmc-domain">iid</journal-id><journal-id journal-id-type="publisher-id">IID3</journal-id><journal-title-group><journal-title>Immunity, Inflammation and Disease</journal-title></journal-title-group><issn pub-type="epub">2050-4527</issn><publisher><publisher-name>Wiley</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10108684</article-id><article-id pub-id-type="pmcid-ver">PMC10108684.1</article-id><article-id pub-id-type="pmcaid">10108684</article-id><article-id pub-id-type="pmcaiid">10108684</article-id><article-id pub-id-type="pmid">37102657</article-id><article-id pub-id-type="doi">10.1002/iid3.825</article-id><article-id pub-id-type="publisher-id">IID3825</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="overline"><subject>Original Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Original Articles</subject></subj-group></article-categories><title-group><article-title>Characterization of the lung microbiome and inflammatory cytokine levels in women exposed to environmental risk factors: A pilot study</article-title><alt-title alt-title-type="left-running-head">MORALES&#8208;GONZ&#193;LEZ <sc>et al.</sc></alt-title></title-group><contrib-group><contrib id="iid3825-cr-0001" contrib-type="author"><name name-style="western"><surname>Morales&#8208;Gonz&#225;lez</surname><given-names initials="F">Fernando</given-names></name><xref rid="iid3825-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="iid3825-cr-0002" contrib-type="author"><name name-style="western"><surname>Lira&#8208;Lucio</surname><given-names initials="JA">Juan A.</given-names></name><xref rid="iid3825-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="iid3825-cr-0003" contrib-type="author"><name name-style="western"><surname>Falf&#225;n&#8208;Valencia</surname><given-names initials="R">Ramc&#233;s</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-6877-8124</contrib-id><xref rid="iid3825-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="iid3825-cr-0004" contrib-type="author"><name name-style="western"><surname>M&#225;rquez&#8208;Garc&#237;a</surname><given-names initials="JE">Jos&#233; E.</given-names></name><xref rid="iid3825-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="iid3825-cr-0005" contrib-type="author"><name name-style="western"><surname>Abarca&#8208;Rojano</surname><given-names initials="E">Edgar</given-names></name><xref rid="iid3825-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="iid3825-cr-0006" contrib-type="author"><name name-style="western"><surname>Ram&#237;rez&#8208;Venegas</surname><given-names initials="A">Alejandra</given-names></name><xref rid="iid3825-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="iid3825-cr-0007" contrib-type="author"><name name-style="western"><surname>Sansores</surname><given-names initials="RH">Ra&#250;l H.</given-names></name><xref rid="iid3825-aff-0005" ref-type="aff">
<sup>5</sup>
</xref></contrib><contrib id="iid3825-cr-0008" contrib-type="author"><name name-style="western"><surname>Garc&#237;a&#8208;G&#243;mez</surname><given-names initials="L">Leonor</given-names></name><xref rid="iid3825-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="iid3825-cr-0009" contrib-type="author"><name name-style="western"><surname>Hern&#225;ndez&#8208;P&#233;rez</surname><given-names initials="A">Andrea</given-names></name><xref rid="iid3825-aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="iid3825-cr-0010" contrib-type="author" corresp="yes"><name name-style="western"><surname>P&#233;rez&#8208;Rubio</surname><given-names initials="G">Gloria</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-6876-1012</contrib-id><xref rid="iid3825-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>gperezrubio@iner.gob.mx</email></address></contrib></contrib-group><aff id="iid3825-aff-0001">
<label>
<sup>1</sup>
</label>
<institution>HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cos&#237;o Villegas</institution>
<city>Mexico City</city>
<country country="MX">Mexico</country>
</aff><aff id="iid3825-aff-0002">
<label>
<sup>2</sup>
</label>
<institution>Subdirecci&#243;n de Investigaci&#243;n Biom&#233;dica, Instituto Nacional de Enfermedades Respiratorias Ismael Cos&#237;o Villegas</institution>
<city>Mexico City</city>
<country country="MX">Mexico</country>
</aff><aff id="iid3825-aff-0003">
<label>
<sup>3</sup>
</label>
<institution>Secci&#243;n de Estudios de Posgrado e Investigaci&#243;n, Escuela Superior de Medicina, Instituto Polit&#233;cnico Nacional</institution>
<city>Mexico City</city>
<country country="MX">Mexico</country>
</aff><aff id="iid3825-aff-0004">
<label>
<sup>4</sup>
</label>
<named-content content-type="organisation-division">Department of Tobacco Smoking and COPD Research</named-content>
<institution>Instituto Nacional de Enfermedades Respiratorias Ismael Cos&#237;o Villegas</institution>
<city>Mexico City</city>
<country country="MX">Mexico</country>
</aff><aff id="iid3825-aff-0005">
<label>
<sup>5</sup>
</label>
<institution>Cl&#237;nica de Enfermedades Respiratorias, Fundaci&#243;n M&#233;dica Sur</institution>
<city>Mexico City</city>
<country country="MX">Mexico</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold> Gloria P&#233;rez&#8208;Rubio, Instituto Nacional de Enfermedades Respiratorias Ismael Cos&#237;o Villegas, Mexico City 14080, Mexico.<break/>
Email: <email>gperezrubio@iner.gob.mx</email><break/></corresp></author-notes><pub-date pub-type="epub"><day>17</day><month>4</month><year>2023</year></pub-date><pub-date pub-type="collection"><month>4</month><year>2023</year></pub-date><volume>11</volume><issue seq="20">4</issue><issue-id pub-id-type="pmc-issue-id">433340</issue-id><issue-id pub-id-type="doi">10.1002/iid3.v11.4</issue-id><elocation-id>e825</elocation-id><history><date date-type="rev-recd"><day>03</day><month>2</month><year>2023</year></date><date date-type="received"><day>18</day><month>7</month><year>2022</year></date><date date-type="accepted"><day>28</day><month>2</month><year>2023</year></date></history><pub-history><event event-type="pmc-release"><date><day>17</day><month>04</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>18</day><month>04</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2024-09-16 13:25:21.953"><day>16</day><month>09</month><year>2024</year></date></event></pub-history><permissions><copyright-statement content-type="article-copyright">&#169; 2023 The Authors. <italic toggle="yes">Immunity, Inflammation and Disease</italic> published by John Wiley &amp; Sons Ltd.</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="IID3-11-e825.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="file:IID3-11-e825.pdf"/><abstract><title>Abstract</title><sec id="iid3825-sec-0010"><title>Introduction</title><p>Lung microbiome dysbiosis affects the immune system balance and promotes lung inflammation. We aimed to characterize and compare the lung bacteriome composition and the cytokine profile in women with normal lung function exposed to risk factors for chronic lung diseases (tobacco smoking and biomass&#8208;burning smoke exposure).</p></sec><sec id="iid3825-sec-0020"><title>Methods</title><p>We included women with biomass&#8208;burning smoke exposure (BE, <italic toggle="yes">n</italic>&#8201;=&#8201;11) and current smokers women (TS, <italic toggle="yes">n</italic>&#8201;=&#8201;10). The bacteriome composition was performed in induced sputum, sequencing the 16 rRNA gene. Cytokine levels were measured using enzyme&#8208;linked immunosorbent assay multiplex assay in the supernatant of induced sputum. For quantitative variables, we used medians and minimum and maxim values. For the amplicon sequence variants (ASV) differential abundance testing between groups.</p></sec><sec id="iid3825-sec-0030"><title>Results</title><p>At the taxa level, the phylum Proteobacteria was found in a higher proportion in the TS group concerning BE (<italic toggle="yes">p</italic>&#8201;=&#8201;.045); however, after the false discovery rate adjustment, this difference was not retained (<italic toggle="yes">p</italic>&#8201;=&#8201;.288). We found a higher concentration of IL&#8208;1&#946; in the TS group than in the BE group (248.6 vs. 177.9&#8201;pg/mL, <italic toggle="yes">p</italic>&#8201;=&#8201;.010). Women with high biomass&#8208;burning smoke exposure in an hour per day had a positive correlation with the abundance of Bacteroidota (<italic toggle="yes">&#961;</italic>&#8201;=&#8201;0.71, <italic toggle="yes">p</italic>&#8201;=&#8201;.014) and Fusobacteriota (<italic toggle="yes">&#961;</italic>&#8201;=&#8201;0.73, <italic toggle="yes">p</italic>&#8201;=&#8201;.011). FEV1/FVC had a positive correlation with an abundance of Bacteroidota, Proteobacteria, and Fusobacteria (<italic toggle="yes">&#961;</italic>&#8201;=&#8201;0.74, <italic toggle="yes">p</italic>&#8201;=&#8201;.009, <italic toggle="yes">&#961;</italic>&#8201;=&#8201;0.85, <italic toggle="yes">p</italic>&#8201;=&#8201;.001, and <italic toggle="yes">&#961;</italic>&#8201;=&#8201;0.83, <italic toggle="yes">p</italic>&#8201;=&#8201;.001, respectively). In tobacco smoking, women had a positive correlation (<italic toggle="yes">&#961;</italic>&#8201;=&#8201;0.77, <italic toggle="yes">p</italic>&#8201;=&#8201;.009) between cigarettes per day and Firmicutes' abundance.</p></sec><sec id="iid3825-sec-0040"><title>Conclusion</title><p>Compared to biomass&#8208;burning smoke&#8208;exposed women, current smokers have poor lung function and high levels of IL&#8208;1&#946; in sputum. Women with biomass&#8208;burning smoke exposure present an increased abundance of Bacteroidota and Fusobacteriota.</p></sec></abstract><abstract abstract-type="graphical"><p>This is the first study that evaluates the bacterial composition in exposed women to known risk factors for lung diseases with normal lung function. The pro&#8208;inflammatory mediators play an essential role in the initiation and maintenance of inflammation.<boxed-text position="anchor" content-type="graphic" orientation="portrait"><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-1" orientation="portrait" xlink:href="IID3-11-e825-g003.jpg"/></boxed-text>
</p></abstract><kwd-group><kwd id="iid3825-kwd-0001">dysbiosis</kwd><kwd id="iid3825-kwd-0002">immunity</kwd><kwd id="iid3825-kwd-0003">inflammation</kwd><kwd id="iid3825-kwd-0004">respiratory disease</kwd><kwd id="iid3825-kwd-0005">respiratory microbiome</kwd></kwd-group><counts><fig-count count="3"/><table-count count="3"/><page-count count="10"/><word-count count="5323"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>April 2023</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.2.7 mode:remove_FC converted:17.04.2023</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="iid3825-cit-0052"><string-name name-style="western"><surname>Morales&#8208;Gonz&#225;lez</surname><given-names>F</given-names></string-name>, <string-name name-style="western"><surname>Lira&#8208;Lucio</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Falf&#225;n&#8208;Valencia</surname><given-names>R</given-names></string-name>, et al. <article-title>Characterization of the lung microbiome and inflammatory cytokine levels in women exposed to environmental risk factors: a pilot study</article-title>. <source>Immun Inflamm Dis</source>. <year>2023</year>;<volume>11</volume>:<elocation-id>e825</elocation-id>. <pub-id pub-id-type="doi">10.1002/iid3.825</pub-id><pub-id pub-id-type="pmcid">PMC10108684</pub-id><pub-id pub-id-type="pmid">37102657</pub-id></mixed-citation>
</p><fn-group><fn id="iid3825-note-0001"><p>Fernando Morales&#8208;Gonz&#225;lez and Juan Alberto Lira&#8208;Lucio contributed equally to this work.</p></fn></fn-group></notes></front><body><sec id="iid3825-sec-0050"><label>1</label><title>INTRODUCTION</title><p>Inhalation of toxic substances such as smoke from biomass combustion (common in poorly ventilated homes) and tobacco smoking are risk factors for developing respiratory tract diseases (lung cancer, chronic obstructive pulmonary disease [COPD], asthma, and others). The compounds and particles in these noxious gases cause changes in pH, oxygen tension, oxidative stress, pro&#8208;inflammatory conditions, and even dysbiosis of the microbiome in the pulmonary microenvironment.<xref rid="iid3825-bib-0001" ref-type="bibr">
<sup>1</sup>
</xref> Five phyla are the most abundant in healthy lungs Firmicutes, Proteobacteria, Bacteroidota, Actinobacteriota, and Fusobacteria.<xref rid="iid3825-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref>, <xref rid="iid3825-bib-0003" ref-type="bibr">
<sup>3</sup>
</xref>, <xref rid="iid3825-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref>
</p><p>Cigarette smoking influences the composition of the lung microbiome,<xref rid="iid3825-bib-0005" ref-type="bibr">
<sup>5</sup>
</xref> reporting a positive correlation between the cigarette smoking years and taxa of the Firmicutes phylum (genera <italic toggle="yes">Veillonella</italic> and <italic toggle="yes">Megasphaera</italic>) and the genus <italic toggle="yes">Prevotella</italic>. At the same time, this variable is inversely associated with Proteobacteria (genera <italic toggle="yes">Eikenella</italic> and <italic toggle="yes">Haemophilus</italic>).<xref rid="iid3825-bib-0006" ref-type="bibr">
<sup>6</sup>
</xref> Furthermore, smokers have a 20%&#8211;30% higher probability of needing antibiotics.<xref rid="iid3825-bib-0007" ref-type="bibr">
<sup>7</sup>
</xref> In COPD patients, Proteobacteria dominant profiles were associated with neutrophil activation markers, and Firmicutes dominant profiles were associated with raised blood eosinophil counts.<xref rid="iid3825-bib-0008" ref-type="bibr">
<sup>8</sup>
</xref> Neutrophilic inflammation in COPD shows a predominance of <italic toggle="yes">Haemophilus</italic> and elevated levels of interleukin (IL)&#8208;1&#946; and tumor necrosis factor (TNF) in the sputum.<xref rid="iid3825-bib-0009" ref-type="bibr">
<sup>9</sup>
</xref> In COPD patients, during exacerbations exist high biosynthesis of lipopolysaccharides; these molecules are components of the cell wall of gram&#8208;negative bacteria<xref rid="iid3825-bib-0010" ref-type="bibr">
<sup>10</sup>
</xref> and are induced locally in the lung release of neutrophils, production of IL&#8208;1, and IL&#8208;6. This inflammatory response contributes to transient airway obstruction.<xref rid="iid3825-bib-0011" ref-type="bibr">
<sup>11</sup>
</xref>
</p><p>Reports regarding the involvement of the lung microbiome due to biomass&#8208;burning exposure are very scarce; this smoke contains thousands of harmful substances, including particulate matter at most 10 (PM10) or 2.5 (PM2.5) microns in diameter.<xref rid="iid3825-bib-0012" ref-type="bibr">
<sup>12</sup>
</xref> Smoke exposure is more prevalent in women in rural and suburban regions. In these cases, they use biomass fuel to cook and heat the home.<xref rid="iid3825-bib-0013" ref-type="bibr">
<sup>13</sup>
</xref> Exposure for 30&#8211;40 years to biomass smoke is equivalent to 60,000&#8201;h or inhaling a total volume of 25 million/L of polluted indoor air during their lifetime.<xref rid="iid3825-bib-0014" ref-type="bibr">
<sup>14</sup>
</xref> Indoor PM2.5 concentration in homes using biomass burning is higher than in non&#8208;biomass&#8208;burning (455 vs. 101&#8201;&#956;g/m<sup>3</sup>). The same behavior is observed in 24&#8201;h CO concentrations (13.4&#8201;vs. 2.0&#8201;ppm).<xref rid="iid3825-bib-0015" ref-type="bibr">
<sup>15</sup>
</xref>
</p><p>In the COPD Risk Cohort, the authors evaluated the influence of the environmental PM2.5 concentration on the lung microbiome for 14 days. The microbiome showed significant changes from the sixth day of exposure, especially in some Operational Taxonomic Units (OTUs). This change was maintained until the last monitored day.<xref rid="iid3825-bib-0016" ref-type="bibr">
<sup>16</sup>
</xref> In a Malawian population, they observed that those exposed to high carbon particle levels had a greater abundance of potentially pathogenic bacteria (<italic toggle="yes">Streptococcus</italic> and <italic toggle="yes">Neisseria</italic>).<xref rid="iid3825-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref> Microbiome analysis provides an opportunity to develop novel prognostic markers for airway disease, enhance the definition of clinical phenotypes, acquire additional guidance to aid treatment selection, and increase the precision of indicators of a treatment effect.<xref rid="iid3825-bib-0018" ref-type="bibr">
<sup>18</sup>
</xref> We aimed to characterize and compare the composition of the lung bacteriome and the cytokine profile in women without lung function affectation but exposed to environmental risk factors (tobacco smoking and exposure to smoke from biomass burning) for chronic lung diseases. We included women because, in low and middle&#8208;income countries, they have a leading role in domestic, and the use of biomass has been a necessity for cooking or household heating; while men are at work or away from home.<xref rid="iid3825-bib-0019" ref-type="bibr">
<sup>19</sup>
</xref>
</p></sec><sec sec-type="materials-and-methods" id="iid3825-sec-0060"><label>2</label><title>MATERIALS AND METHODS</title><sec id="iid3825-sec-0070"><label>2.1</label><title>Study population</title><p>We designed an observational, descriptive, and retrospective study, including women with biomass&#8208;burning smoke exposure (BE, <italic toggle="yes">n</italic>&#8201;=&#8201;11), recruited in rural and suburban populations by the Department of Research in Smoking and COPD (DITABE) of the Instituto Nacional de Enfermedades Respiratorias Ismael Cos&#237;o Villegas (INER) in Mexico City and current smoking women (TS, <italic toggle="yes">n</italic>&#8201;=&#8201;10). The general inclusion criteria were women, age &#8805;40 years, with lung function test (forced expiratory volume in 1 second/forced vital capacity [FEV1/FVC]) values of &#8805;70%. The TS group had a history of &#8805;3 packs per year, and the BE group had a biomass smoke exposure index (BSEI) of &#8805;100&#8201;h per year. Both groups had exposure to corresponding environmental risk factors for &#8805;10 years. In addition, all participants had a physical examination by pulmonology specialists. The exclusion criteria were a record of respiratory diseases (asthma, COPD, cystic fibrosis, bronchiectasis, lung cancer, hypersensitivity pneumonitis, idiopathic pulmonary fibrosis, lung tuberculosis, etc.), lung transplant, cerebrovascular disease, psychiatric disorders, infectious disease, antibiotics, or immunosuppressive treatments in the previous 3 months, or evidence of acute upper respiratory symptoms for the preceding 4 weeks.</p><p>We applied a questionnaire to each participant about their place of birth, region of residence, ethnicity, sex, and employment status, including anthropometric characteristics, tobacco index (TI), or BSEI.</p><p>The lung function tests were performed by spirometry technicians considering the criteria established by the American Thoracic Society and the values calculated in the Mexican population.<xref rid="iid3825-bib-0020" ref-type="bibr">
<sup>20</sup>
</xref> For postbronchodilator spirometry, a single&#8208;dose salbutamol was administered using an inhaler and spacer.<xref rid="iid3825-bib-0021" ref-type="bibr">
<sup>21</sup>
</xref>
</p></sec><sec id="iid3825-sec-0080"><label>2.2</label><title>Sputum induction, processing, and bacterial DNA extraction</title><p>The women who agreed to participate voluntarily and signed an informed consent document were provided with a personal data protection certificate. The INER committee reviewed and approved the study on bioethics and research (protocol number B01&#8208;17).</p><p>The women were required to stop smoking or leave biomass&#8208;smoke exposure for at least 12&#8201;h before sample collection. Then, for sputum induction, the participant rinsed their mouth with water. Next, we administered sterile saline solution (7%) by nebulization for 5&#8201;min, followed by a 5&#8208;min break. Participants performed this technique a maximum of three times.<xref rid="iid3825-bib-0022" ref-type="bibr">
<sup>22</sup>
</xref> Finally, sputum was collected into sterile containers and transported to the laboratory.</p><p>In a biosafety cabinet, using a transfer pipette, saliva was eliminated. In a 1:1 relation, sterile saline solution (0.9%) was added to sputum using a sterile syringe and 20&#8208;gauge needle to disaggregate sputum (up and down a minimum of 10 times); subsequently, we used a 22&#8208;gauge needle until complete disintegration. The resulting sample was filtered (Falcon 70&#8201;&#181;m Cell Strainer) and centrifuged at 3000&#8201;rpm at 20&#176;C for 10&#8201;min. The supernatant was stored at &#8722;80&#176;C. The cellular pellet was employed for bacterial DNA extraction. Bacterial DNA was purified using the ZymoBIOMICS&#8482; DNA Miniprep Kit (Zymo Research Corp.), following the instructions for liquid samples (200&#8201;&#181;L) as the supplier recommends. The DNA was quantitated utilizing the Qubit dsDNA High Sensitivity (HS) Assay Kit (Invitrogen) and assessed for integrity by electrophoresis on agarose gel. We included two saline samples to identify bacteria procedures of sources of contamination; these controls were treated in the same conditions that the sputum samples.</p></sec><sec id="iid3825-sec-0090"><label>2.3</label><title>The 16Sr DNA metagenomic sequencing: Library preparation and sequencing</title><p>The libraries were prepared for targeted amplicon sequencing following the &#8220;16&#8201;Sr DNA Metagenomic Sequencing Library Preparation&#8221; guide (Part# 15044223 Rev. B, Illumina). We used the primer pair sequence for the V3 and V4 regions of the 16&#8201;S ribosomal RNA gene (16&#8201;Sr DNA), Nextera XT indices, and PhiX control. The sequencing was performed on the MiSeq platform using paired 300&#8201;bp reads and MiSeq v3 reagents. We employed MiSeq Control Software v 3.1.1.13 (Illumina) to generate the FASTQ files.</p></sec><sec id="iid3825-sec-0100"><label>2.4</label><title>Bioinformatic analysis of the 16&#8201;Sr DNA sequences</title><p>We analyzed FASTQ files using RStudio,<xref rid="iid3825-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref> packages dada2,<xref rid="iid3825-bib-0024" ref-type="bibr">
<sup>24</sup>
</xref> phyloseq,<xref rid="iid3825-bib-0025" ref-type="bibr">
<sup>25</sup>
</xref> DESeq.2,<xref rid="iid3825-bib-0026" ref-type="bibr">
<sup>26</sup>
</xref> ggplot2,<xref rid="iid3825-bib-0027" ref-type="bibr">
<sup>27</sup>
</xref> microbiome,<xref rid="iid3825-bib-0028" ref-type="bibr">
<sup>28</sup>
</xref> and a workflow for microbiome data analysis of Bioconductor (open&#8208;source software for bioinformatics)<xref rid="iid3825-bib-0029" ref-type="bibr">
<sup>29</sup>
</xref> was used. We employed the database of silva nr v138 and 97% similarity level to assign taxonomy.<xref rid="iid3825-bib-0030" ref-type="bibr">
<sup>30</sup>
</xref> Community richness estimators included Chao1, Shannon, and Simpson indexes. The amplicon sequence variants (ASV) were obtained. Finally, the reads were normalized by cumulative&#8208;sum scaling.<xref rid="iid3825-bib-0026" ref-type="bibr">
<sup>26</sup>
</xref>
</p></sec><sec id="iid3825-sec-0110"><label>2.5</label><title>Cytokines' immunoassay</title><p>According to the manufacturer's instructions, sputum supernatant cytokine levels were determined using a commercially available multiplex Human Cytokine Magnetic 10&#8208;Plex Panel (Thermo Fisher Scientific). Proteins evaluated include IL&#8208;1&#946;, IL&#8208;2, IL&#8208;4, IL&#8208;5, IL&#8208;6, IL&#8208;8, IL&#8208;10, tumor necrosis factor (TNF)&#8208;&#945;, Interferon (IFN)&#8208;&#947;, and granulocyte&#8208;macrophage colony&#8208;stimulating factor (GM&#8208;CSF).</p><p>The multiplex assay was performed according to the manufacturer's instructions. Samples were homogenized and adjusted for further quantification in the Luminex LAB&#8208;Scan 100 (Luminex Corp.) system. The cytokine concentrations were calculated using the standard curve. The xPONENT 3.1 software (Luminex Corp.) was used for data acquisition.</p></sec><sec id="iid3825-sec-0120"><label>2.6</label><title>Statistical analysis</title><p>The analysis for anthropometric characteristics, TI or BSEI, spirometry data, and cytokine levels was performed using SPSS version 15 (SPSS software, IBM). For quantitative variables, we used a mean and standard deviation or medians and minimum and maxim values according to the distribution of the variables and used parametric or non&#8208;parametric tests. Alpha diversity was also assessed using the Mann&#8211;Whitney <italic toggle="yes">U</italic> test. For the ASV differential abundance testing between groups, we employed the negative binomial generalized linear model (GLM) and obtained maximum likelihood estimates for an ASV log&#8208;fold change between two study groups; the p&#8208;value was adjusted by the false discovery rate (FDR) method.<xref rid="iid3825-bib-0031" ref-type="bibr">
<sup>31</sup>
</xref> Furthermore, the p&#8208;value of cytokine levels in sputum supernatant was obtained by the Mann&#8211;Whitney <italic toggle="yes">U</italic> test with a Bonferroni posthoc correction. A value of <italic toggle="yes">p</italic>&#8201;&lt;&#8201;.05 was considered statistically significant. For the quantitative variables and abundance of bacteria, Spearman's correlation was made. The description of the results was carried out using the ggplot2<xref rid="iid3825-bib-0026" ref-type="bibr">
<sup>26</sup>
</xref>, <xref rid="iid3825-bib-0027" ref-type="bibr">
<sup>27</sup>
</xref> and corrplot<xref rid="iid3825-bib-0032" ref-type="bibr">
<sup>32</sup>
</xref> packages in RStudio.<xref rid="iid3825-bib-0023" ref-type="bibr">
<sup>23</sup>
</xref>
</p></sec></sec><sec sec-type="results" id="iid3825-sec-0130"><label>3</label><title>RESULTS</title><sec id="iid3825-sec-0140"><label>3.1</label><title>Study population</title><p>The groups included in the study did not show statistically significant differences in age, body mass index, forced vital capacity (FVC), or expiratory volume in the first second (FEV1), as shown in Table&#160;<xref rid="iid3825-tbl-0001" ref-type="table">1</xref>. All the women in the TS group were from Mexico City. The TI was 16.7 packages per year, and they reported starting to smoke at 15 years old (12&#8211;25 years).</p><table-wrap position="float" id="iid3825-tbl-0001" content-type="Table" orientation="portrait"><label>Table 1</label><caption><p>Characteristics of the women included in the study.</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000" valign="bottom"><th align="left" valign="bottom" rowspan="1" colspan="1">Variable</th><th align="left" valign="bottom" rowspan="1" colspan="1">BE (<italic toggle="yes">n</italic>&#8201;=&#8201;11)</th><th align="left" valign="bottom" rowspan="1" colspan="1">TS (<italic toggle="yes">n</italic>&#8201;=&#8201;10)</th><th align="left" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>&#8208;value<sup>a</sup>
</th></tr></thead><tbody valign="top"><tr><td valign="top" rowspan="1" colspan="1">Age (years)</td><td valign="top" rowspan="1" colspan="1">60 (41&#8211;74)</td><td valign="top" rowspan="1" colspan="1">53 (47&#8211;64)</td><td valign="top" rowspan="1" colspan="1">.114</td></tr><tr><td valign="top" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td><td valign="top" rowspan="1" colspan="1">28.1 (22.9&#8211;38.8)</td><td valign="top" rowspan="1" colspan="1">27.3 (24.7&#8211;32.0)</td><td valign="top" rowspan="1" colspan="1">.973</td></tr><tr><td valign="top" rowspan="1" colspan="1">TI (package&#8208;year)</td><td valign="top" rowspan="1" colspan="1">&#8211;</td><td valign="top" rowspan="1" colspan="1">16.7 (4&#8211;80)</td><td valign="top" rowspan="1" colspan="1">&#8211;</td></tr><tr><td valign="top" rowspan="1" colspan="1">BSEI (hours&#8208;years)</td><td valign="top" rowspan="1" colspan="1">216 (120&#8211;480)</td><td valign="top" rowspan="1" colspan="1">&#8211;</td><td valign="top" rowspan="1" colspan="1">&#8211;</td></tr><tr><td valign="top" rowspan="1" colspan="1">Communities, <italic toggle="yes">n</italic> (%)</td><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">Urban</td><td valign="top" rowspan="1" colspan="1">0</td><td valign="top" rowspan="1" colspan="1">10 (100)</td><td valign="top" rowspan="1" colspan="1">&#8211;</td></tr><tr><td valign="top" rowspan="1" colspan="1">Rural and suburban</td><td valign="top" rowspan="1" colspan="1">5 (45.5)</td><td valign="top" rowspan="1" colspan="1">0</td><td valign="top" rowspan="1" colspan="1"/></tr><tr><td valign="top" rowspan="1" colspan="1">FVC %<xref rid="iid3825-tbl1-note-0004" ref-type="table-fn">
<sup>b</sup>
</xref>
</td><td valign="top" rowspan="1" colspan="1">102 (86&#8211;134)</td><td valign="top" rowspan="1" colspan="1">90 (81&#8211;124)</td><td valign="top" rowspan="1" colspan="1">.223</td></tr><tr><td valign="top" rowspan="1" colspan="1">FEV1%<xref rid="iid3825-tbl1-note-0004" ref-type="table-fn">
<sup>b</sup>
</xref>
</td><td valign="top" rowspan="1" colspan="1">110 (90&#8211;155)</td><td valign="top" rowspan="1" colspan="1">94 (82&#8211;131)</td><td valign="top" rowspan="1" colspan="1">.099</td></tr><tr><td valign="top" rowspan="1" colspan="1">FEV1/FVC %<xref rid="iid3825-tbl1-note-0004" ref-type="table-fn">
<sup>b</sup>
</xref>
</td><td valign="top" rowspan="1" colspan="1">96 (82&#8211;114)</td><td valign="top" rowspan="1" colspan="1">83 (71&#8211;88)</td><td valign="top" rowspan="1" colspan="1">.001</td></tr></tbody></table><table-wrap-foot><fn id="iid3825-tbl1-note-0001"><p>
<italic toggle="yes">Note</italic>: Showing medians (minimum&#8211;maxim values).</p></fn><fn id="iid3825-tbl1-note-0002"><p>Abbreviations: BE, biomass&#8208;smoke exposed women; BMI, body mass index; BSEI, biomass smoke exposure index; FEV1, forced expiratory volume in the first second; FVC, forced vital capacity; TI, tobacco index; TS, tobacco smoking women.</p></fn><fn id="iid3825-tbl1-note-0003"><label>
<sup>a</sup>
</label><p>
<italic toggle="yes">p</italic>&#8208;value by the Mann&#8211;Whitney <italic toggle="yes">U</italic> test.</p></fn><fn id="iid3825-tbl1-note-0004"><label>b</label><p>Spirometry values are post&#8208;bronchodilator.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder></permissions></table-wrap><p>Regarding the BE group, 45.5% of the women were born in Oaxaca state, the rest in the State of Mexico's rural and suburban areas, and reported having &gt;210&#8201;h per year of exposure to smoke from biomass burning. The participants did not present any lung affection. The post&#8208;bronchodilator FEV1/FVC was &gt;70% in the study groups; however, the TS group had a lower FEV1/FVC ratio than the BE group (<italic toggle="yes">p</italic>&#8201;=&#8201;.001).</p></sec><sec id="iid3825-sec-0150"><label>3.2</label><title>Composition of lung bacteriome</title><p>We obtained &gt;100,000 reads by sample. Comparing the bacterial composition in both study groups did not show a statistically significant difference in alpha diversity (Chao, <italic toggle="yes">p</italic>&#8201;=&#8201;.973; Shannon, <italic toggle="yes">p</italic>&#8201;=&#8201;.173; and Simpson, <italic toggle="yes">p</italic>&#8201;=&#8201;.282). The most abundant phyla were Actinobacteriota, Firmicutes, Bacteroidota, Proteobacteria, and Fusobacteriota. Proteobacteria was found in a higher proportion in the TS group concerning BE (<italic toggle="yes">p</italic>&#8201;=&#8201;.045); however, after the adjustment by FDR, this difference was not maintained (<italic toggle="yes">p</italic>&#8201;=&#8201;.288) (Figure&#160;<xref rid="iid3825-fig-0001" ref-type="fig">1A</xref>). The top five genera found were <italic toggle="yes">Streptococcus</italic>, <italic toggle="yes">Veillonella</italic>, <italic toggle="yes">Haemophilus</italic>, <italic toggle="yes">Rothia</italic>, and <italic toggle="yes">Prevotella</italic> (Figure&#160;<xref rid="iid3825-fig-0001" ref-type="fig">1B</xref>). However, there was no difference in relative abundance when groups were compared (Table&#160;<xref rid="iid3825-tbl-0002" ref-type="table">2</xref>). The data sets presented in this study (FASTQ file) can be found in online repositories (Sequence Read Archive, SRA; submission: SUB9326500).</p><fig position="float" fig-type="Figure" id="iid3825-fig-0001" orientation="portrait"><label>Figure 1</label><caption><p>(A) Relative abundance in the study groups at the phylum level by the group. (B) relative abundance in the study BE versus TS by participants at the genus level. The numbers 1&#8211;11 correspond to the Biomass&#8208;smoke exposed (BE) group, and A to J corresponds to tobacco smoking (TS).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-3" orientation="portrait" xlink:href="IID3-11-e825-g002.jpg"/></fig><table-wrap position="float" id="iid3825-tbl-0002" content-type="Table" orientation="portrait"><label>Table 2</label><caption><p>Differential abundance analysis for the top five bacteria between BE and TS.</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000" valign="bottom"><th align="left" valign="bottom" rowspan="1" colspan="1">Phylum</th><th align="left" valign="bottom" rowspan="1" colspan="1">Class</th><th align="left" valign="bottom" rowspan="1" colspan="1">Order</th><th align="left" valign="bottom" rowspan="1" colspan="1">Family</th><th align="left" valign="bottom" rowspan="1" colspan="1">Genus</th><th align="left" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>&#8208;value<xref rid="iid3825-tbl2-note-0002" ref-type="table-fn">*</xref>
</th></tr></thead><tbody valign="top"><tr><td rowspan="2" valign="top" colspan="1">Firmicutes</td><td valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Bacilli</italic>
</td><td valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Lactobacillales</italic>
</td><td valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Streptococcaceae</italic>
</td><td valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Streptococcus</italic>
</td><td valign="top" rowspan="1" colspan="1">.135</td></tr><tr><td valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Negativicutes</italic>
</td><td valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Veillonellales&#8208;Selenomonadales</italic>
</td><td valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Veillonellaceae</italic>
</td><td valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Veillonella</italic>
</td><td valign="top" rowspan="1" colspan="1">.455</td></tr><tr><td valign="top" rowspan="1" colspan="1">Proteobacteria</td><td valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Gammaproteobacteria</italic>
</td><td valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Pasteurellales</italic>
</td><td valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Pasteurellaceae</italic>
</td><td valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Haemophilus</italic>
</td><td valign="top" rowspan="1" colspan="1">.291</td></tr><tr><td valign="top" rowspan="1" colspan="1">Actinobacteriota</td><td valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Actinobacteria</italic>
</td><td valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Micrococcales</italic>
</td><td valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Micrococcaceae</italic>
</td><td valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Rothia</italic>
</td><td valign="top" rowspan="1" colspan="1">.246</td></tr><tr><td valign="top" rowspan="1" colspan="1">Bacteroidota</td><td valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Bacteroidia</italic>
</td><td valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Bacteroidales</italic>
</td><td valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Prevotellaceae</italic>
</td><td valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Prevotella</italic>
</td><td valign="top" rowspan="1" colspan="1">.511</td></tr><tr><td rowspan="2" valign="top" colspan="1">Fusobacteriota</td><td rowspan="2" valign="top" colspan="1">
<italic toggle="yes">Fusobacteriia</italic>
</td><td rowspan="2" valign="top" colspan="1">
<italic toggle="yes">Fusobacteriales</italic>
</td><td valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Fusobacteriaceae</italic>
</td><td valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Fusobacterium</italic>
</td><td valign="top" rowspan="1" colspan="1">.912</td></tr><tr><td valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Leptotrichiaceae</italic>
</td><td valign="top" rowspan="1" colspan="1">
<italic toggle="yes">Leptotrichia</italic>
</td><td valign="top" rowspan="1" colspan="1">.926</td></tr></tbody></table><table-wrap-foot><fn id="iid3825-tbl2-note-0001"><p>Abbreviations: BE, biomass&#8208;smoke exposed women; TS, tobacco smoking women.</p></fn><fn id="iid3825-tbl2-note-0002"><label>*</label><p>
<italic toggle="yes">p</italic>&#8208;value was adjusted by the false discovery rate (FDR) method.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder></permissions></table-wrap><p>In women exposed to biomass&#8208;burning smoke, BSEI had a positive correlation with biomass&#8208;burning smoke exposure in hours per day (BiEx) and abundance of Bacteroidota (<italic toggle="yes">&#961;</italic>&#8201;=&#8201;0.71, <italic toggle="yes">p</italic>&#8201;=&#8201;.014) and Fusobacteriota (<italic toggle="yes">&#961;</italic>&#8201;=&#8201;0.73, <italic toggle="yes">p</italic>&#8201;=&#8201;.011). FEV1/FVC had a positive correlation with an abundance of Bacteroidota, Proteobacteria, and Fusobacteria (<italic toggle="yes">&#961;</italic>&#8201;=&#8201;0.74, <italic toggle="yes">p</italic>&#8201;=&#8201;.009, <italic toggle="yes">&#961;</italic>&#8201;=&#8201;0.85, <italic toggle="yes">p</italic>&#8201;=&#8201;.001, and <italic toggle="yes">&#961;</italic>&#8201;=&#8201;0.83, <italic toggle="yes">p</italic>&#8201;=&#8201;.001, respectively). In the bacterial abundance analysis, we found that Firmicutes and Actinobacteria had a positive correlation (<italic toggle="yes">&#961;</italic>&#8201;=&#8201;0.88, <italic toggle="yes">p</italic>&#8201;&lt;&#8201;.001). Bacteroidota had a positive correlation with Proteobacteria and Fusobacteriota (<italic toggle="yes">p</italic>&#8201;=&#8201;.001, &#961;&#8201;=&#8201;0.77 and <italic toggle="yes">p</italic>&#8201;=&#8201;.003, &#961;&#8201;=&#8201;0.80, respectively) and Proteobacteria had a positive correlation with Fusobacteriota (<italic toggle="yes">p</italic>&#8201;&lt;&#8201;.001, <italic toggle="yes">&#961;</italic>&#8201;=&#8201;0.90) (Figure&#160;<xref rid="iid3825-fig-0002" ref-type="fig">2A</xref>).</p><fig position="float" fig-type="Figure" id="iid3825-fig-0002" orientation="portrait"><label>Figure 2</label><caption><p>(A) Correlation analysis in women exposed to biomass&#8208;burning smoke. (B) Correlation analysis in tobacco smoking group. *<italic toggle="yes">p</italic>&#8201;&lt;&#8201;.05, **<italic toggle="yes">p</italic>&#8201;&lt;&#8201;.01. BiEx, biomass&#8208;burning smoke exposure in hours per day; BSEI, biomass smoke exposure index; cpd, cigarette per day; FEV1, Forced expiratory volume in the first second; FVC, forced vital capacity; SY, smoking years; TI, tobacco index; YBi, years to biomass&#8208;burning smoke exposure.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-5" orientation="portrait" xlink:href="IID3-11-e825-g001.jpg"/></fig><p>In the analysis for the tobacco smoking group, we identified a positive correlation between cpd and Firmicutes (<italic toggle="yes">p</italic>&#8201;=&#8201;.009, <italic toggle="yes">&#961;</italic>&#8201;=&#8201;0.77). Firmicutes versus Proteobacteria and Actinobacteriota showed a positive correlation (<italic toggle="yes">p</italic>&#8201;=&#8201;.021, <italic toggle="yes">&#961;</italic>&#8201;=&#8201;0.71; <italic toggle="yes">p</italic>&#8201;=&#8201;.002, <italic toggle="yes">&#961;</italic>&#8201;=&#8201;0.85, respectively), and Proteobacteria and Actinobacteriota (<italic toggle="yes">p</italic>&#8201;=&#8201;.024, <italic toggle="yes">&#961;</italic>&#8201;=&#8201;0.70) (Figure&#160;<xref rid="iid3825-fig-0002" ref-type="fig">2B</xref>).</p><p>To assess whether the abundance of the obtained phylum correlated with the lung function of the patients, regardless of environmental exposure, we make Spearman's correlation analysis. Fusobacteriota showed a moderate positive correlation with FEV1% and FVC % postbronchodilator (<italic toggle="yes">p</italic>&#8201;=&#8201;.031, rho&#8201;=&#8201;0.47 and <italic toggle="yes">p</italic>&#8201;=&#8201;.028, rho&#8201;=&#8201;0.48 respectively) (Figure&#160;<xref rid="iid3825-suppl-0001" ref-type="supplementary-material">S1A,B</xref>).</p></sec><sec id="iid3825-sec-0160"><label>3.3</label><title>Cytokines analysis</title><p>Regarding evaluated cytokines (Table&#160;<xref rid="iid3825-tbl-0003" ref-type="table">3</xref>), we found a higher concentration of IL&#8208;1&#946; in the TS group with respect to the BE group (248.6 vs. 177.9&#8201;pg/mL, <italic toggle="yes">p</italic>&#8201;=&#8201;.001) as well as GM&#8208;CSF (142.2 vs. 140.6&#8201;pg/mL, <italic toggle="yes">p</italic>&#8201;=&#8201;.021) and IL&#8208;2 (241.1 vs. 218.6&#8201;pg/mL, <italic toggle="yes">p</italic>&#8201;=&#8201;.340); however, with a Bonferroni posthoc correction, only IL&#8208;1&#946; maintained a significant association (<italic toggle="yes">p</italic>&#8201;=&#8201;.010).</p><table-wrap position="float" id="iid3825-tbl-0003" content-type="Table" orientation="portrait"><label>Table 3</label><caption><p>Sputum supernatant cytokine levels in both study groups.</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" span="1"/><thead valign="bottom"><tr style="border-bottom:solid 1px #000000" valign="bottom"><th align="left" valign="bottom" rowspan="1" colspan="1">Cytokine (pg/mL)</th><th align="left" valign="bottom" rowspan="1" colspan="1">BE (<italic toggle="yes">n</italic>&#8201;=&#8201;11)</th><th align="left" valign="bottom" rowspan="1" colspan="1">TS (<italic toggle="yes">n</italic>&#8201;=&#8201;10)</th><th align="left" valign="bottom" rowspan="1" colspan="1">
<italic toggle="yes">p</italic>&#8208;value<xref rid="iid3825-tbl3-note-0003" ref-type="table-fn">*</xref>
</th></tr></thead><tbody valign="top"><tr><td valign="top" rowspan="1" colspan="1">IL&#8208;1&#946;</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">177.9 (14.7&#8211;244.3)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">248.6 (239.9&#8211;271.6)</td><td valign="top" rowspan="1" colspan="1">
<bold>.010</bold>
</td></tr><tr><td valign="top" rowspan="1" colspan="1">IL&#8208;10</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">179.3 (137.5&#8211;184.7)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">184.7 (178.2&#8211;186.9)</td><td valign="top" rowspan="1" colspan="1">NS</td></tr><tr><td valign="top" rowspan="1" colspan="1">IL&#8208;6</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">264.8 (29.0&#8211;518.6)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">107.6 (80.3&#8211;134.9)</td><td valign="top" rowspan="1" colspan="1">NS</td></tr><tr><td valign="top" rowspan="1" colspan="1">GM&#8208;CSF</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">140.6 (43.3&#8211;98.9)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">142.2 (140.6&#8211;158.3)</td><td valign="top" rowspan="1" colspan="1">NS</td></tr><tr><td valign="top" rowspan="1" colspan="1">IL&#8208;5</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">362.8 (115.3&#8211;367.6)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">364.9 (362.8&#8211;367.1)</td><td valign="top" rowspan="1" colspan="1">NS</td></tr><tr><td valign="top" rowspan="1" colspan="1">IFN&#8208;&#947;</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">75.2 (60.7&#8211;111.83)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">72.7 (65.9&#8211;79.4)</td><td valign="top" rowspan="1" colspan="1">NS</td></tr><tr><td valign="top" rowspan="1" colspan="1">TNF&#8208;&#945;</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">66.8 (29.4&#8211;82.8)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">64.7 (63.1&#8211;69.7)</td><td valign="top" rowspan="1" colspan="1">NS</td></tr><tr><td valign="top" rowspan="1" colspan="1">IL&#8208;2</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">218.6 (21.7&#8211;255.9)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">241.1 (203.7&#8211;285.8)</td><td valign="top" rowspan="1" colspan="1">NS</td></tr><tr><td valign="top" rowspan="1" colspan="1">IL&#8208;4</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">62.8 (62.8&#8211;715.6)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">62.8 (62.8&#8211;84.6)</td><td valign="top" rowspan="1" colspan="1">NS</td></tr><tr><td valign="top" rowspan="1" colspan="1">IL&#8208;8</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">1566.8 (894.5&#8211;4745.3)</td><td align="char" char="(" valign="top" rowspan="1" colspan="1">1613.6 (1493.9&#8211;1655.1)</td><td valign="top" rowspan="1" colspan="1">NS</td></tr></tbody></table><table-wrap-foot><fn id="iid3825-tbl3-note-0001"><p>
<italic toggle="yes">Note</italic>: Showing medians (minimum&#8211;maxim values).</p></fn><fn id="iid3825-tbl3-note-0002"><p>Abbreviations: BE, biomass&#8208;smoke exposed women; NS, nonsignificative; TS, tobacco&#8208;smoking women.</p></fn><fn id="iid3825-tbl3-note-0003"><label>*</label><p>
<italic toggle="yes">p</italic>&#8208;value was obtained by the Mann&#8211;Whitney <italic toggle="yes">U</italic> test with a Bonferroni post hoc correction.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder></permissions></table-wrap></sec></sec><sec sec-type="discussion" id="iid3825-sec-0170"><label>4</label><title>DISCUSSION</title><p>The current study was carried out in women with exposure to known risk factors for the development of chronic lung diseases and without the presence of airflow limitation (FEV1/FVC&#8201;&#8805;&#8201;70).<xref rid="iid3825-bib-0033" ref-type="bibr">
<sup>33</sup>
</xref> We found that the FEV1/FVC ratio of the TS group was lower compared to the BE group (83% vs. 96%). Previously, it has been reported that former smokers and low&#8208;intensity current smokers (&lt;5 cigarettes per day) have faster lung function deterioration compared to never&#8208;smokers.<xref rid="iid3825-bib-0034" ref-type="bibr">
<sup>34</sup>
</xref> Smoking is associated with a large range of alterations in systemic immune and inflammation marker levels.<xref rid="iid3825-bib-0035" ref-type="bibr">
<sup>35</sup>
</xref> Patients with COPD secondary to tobacco smoking had more significant airflow obstruction,<xref rid="iid3825-bib-0036" ref-type="bibr">
<sup>36</sup>
</xref> irritation, cough, phlegm, chronic bronchitis,<xref rid="iid3825-bib-0037" ref-type="bibr">
<sup>37</sup>
</xref> higher FEV1 drop, and a higher degree of emphysema compared to COPD patients secondary to biomass smoke.<xref rid="iid3825-bib-0038" ref-type="bibr">
<sup>38</sup>
</xref>
</p><p>We used sputum specimens to evaluate the microbiome in the women in the present study. The presence of oropharyngeal microbiota does not confuse the meaningful microbial signal in sputum, which is correlated with established indices of lung health.<xref rid="iid3825-bib-0002" ref-type="bibr">
<sup>2</sup>
</xref> The human respiratory tract harbors a homogeneous microbiota that decreases bacterial biomass from the upper to the lower tract.<xref rid="iid3825-bib-0039" ref-type="bibr">
<sup>39</sup>
</xref> The present study's alpha diversity does not show a statistically significant difference in both groups. Previously, a similar finding has been reported among patients with idiopathic interstitial pneumonia, sarcoidosis, and <italic toggle="yes">Pneumocystis</italic> pneumonia.<xref rid="iid3825-bib-0040" ref-type="bibr">
<sup>40</sup>
</xref>
</p><p>The pulmonary bacterioma showed that the phylum Proteobacteria was statistically higher in the TS group concerning the BE group; however, this difference was not maintained after the Bonferroni correction (<italic toggle="yes">p</italic>&#8201;=&#8201;.288). The genera most abundant were <italic toggle="yes">Streptococcus</italic>, <italic toggle="yes">Veillonella</italic>, <italic toggle="yes">Haemophilus</italic>, <italic toggle="yes">Rothia</italic>, and <italic toggle="yes">Prevotella</italic>. We found no statistically significant difference between the BE and TS groups at the genus level.</p><p>Unfortunately, in this pilot study, we did not have healthy controls; however, we compared our data with previous reports and found that the relative average abundance of Firmicutes was higher (73.5%) in both groups compared to the lung microbiome of healthy subjects (27.8%&#8211;46.0%).<xref rid="iid3825-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref>, <xref rid="iid3825-bib-0041" ref-type="bibr">
<sup>41</sup>
</xref> For Proteobacteria, the relative average abundance in our study (5%) was lower compared to that reported in the literature for volunteers without lung disease (16%&#8211;18.4%). Bacteroidota abundance in the healthy lung was similar to that reported in our study (16% vs. 13.5%). In healthy subjects, Actinobacteriota abundance has an extensive interval (1%&#8211;14%)<xref rid="iid3825-bib-0004" ref-type="bibr">
<sup>4</sup>
</xref>; in our study, we found that 4% of women were exposed to risk factors on average.</p><p>Exposure to smoke from biomass burning has been less explored; however, a biomass study on healthy people showed a higher abundance of <italic toggle="yes">Streptococcus</italic> and <italic toggle="yes">Neisseria</italic> are pathogenic bacteria.<xref rid="iid3825-bib-0017" ref-type="bibr">
<sup>17</sup>
</xref> We found a high concentration of IL&#8208;1&#946;, IL&#8208;2, and GM&#8208;CSF in the TS group compared with BE; however, only IL&#8208;1&#946; maintained a significant difference after Bonferroni correction. IL&#8208;1&#946; is an essential mediator of chronic inflammation and the recruitment of neutrophils, eosinophils, and macrophages. The compounds in the smoke from cigarette smoking cause airway inflammation; an in vitro study of epithelial cells exposed to cigarette smoke extract showed that IL&#8208;1&#946; was expressed 9.5 times more than in unexposed cells.<xref rid="iid3825-bib-0042" ref-type="bibr">
<sup>42</sup>
</xref> In the present communication, IL&#8208;1&#946; was 1.4 times higher in the TS group compared with BE. IL&#8208;1&#946; is a cytokine of innate immunity, involved in the initiation and maintenance of inflammation that participates in mucus hypersecretion and airway remodeling; it is overexpressed in epithelial cells of the small airway of COPD patients.<xref rid="iid3825-bib-0043" ref-type="bibr">
<sup>43</sup>
</xref> Furthermore, it has been associated with an inflammatory mediator in exacerbations of bacterial etiology.<xref rid="iid3825-bib-0044" ref-type="bibr">
<sup>44</sup>
</xref> The cytokine has been described to increase systemic inflammation, emphasizing its importance in exacerbating COPD and asthma.<xref rid="iid3825-bib-0045" ref-type="bibr">
<sup>45</sup>
</xref>
</p><p>In this study, in women with biomass&#8208;burning smoke exposure, no significant correlation between IL&#8208;1&#946; levels and the abundance of OTUs; however, high levels of BiEx increased the abundance of Bacteroidota and Fusobacteriota; Bacteroidota in the gut stimulate TLR2 but not TLR4; in the lung, this mechanism is unknown<xref rid="iid3825-bib-0046" ref-type="bibr">
<sup>46</sup>
</xref>; on the other hand, Fusobacteriota in cavity oral upregulated oncogenes, and promote tumorigenesis<xref rid="iid3825-bib-0047" ref-type="bibr">
<sup>47</sup>
</xref>; however in the lung, there are not reports.</p><p>In this study, we reported that the abundance of Proteobacteria has been correlated with FEV1/FVC in women exposed to biomass burning; the same observation exists in the abundance of Bacteroidota and Fusobacteriota. The phylum Proteobacteria has been associated with asthma<xref rid="iid3825-bib-0048" ref-type="bibr">
<sup>48</sup>
</xref> and in COPD patients induces the production of inflammatory mediators in the lungs of COPD patients, contributing to tissue degradation in the lower airways and increased disease severity Proteobacteria.<xref rid="iid3825-bib-0049" ref-type="bibr">
<sup>49</sup>
</xref> Interestingly, neutrophilic inflammation, increased pro&#8208;inflammatory mediators (IL&#8208;1&#946; level increased significantly), and bacteria&#8208;associated exacerbations with the predominance of Proteobacteria have been reported in a specific cluster with COPD patients that likely respond to antibiotics.<xref rid="iid3825-bib-0050" ref-type="bibr">
<sup>50</sup>
</xref>
</p><p>In smoking women, the cpd was positively correlated whit Firmicutes abundance; previous studies showed that current smoking was strongly associated with the rate of FEV1 decline, and the most abundant phyla was Firmicutes.<xref rid="iid3825-bib-0051" ref-type="bibr">
<sup>51</sup>
</xref>
</p><p>Alterations in the microbiota composition of the respiratory tract have been reported in the development of many chronic lung diseases (cystic fibrosis, COPD, and asthma) and are associated with more advanced conditions. Our pilot study is not exempt from limitations, such as the small sample size or the lack of a group of women without exposure to risk factors (healthy women). However, we included other reports in the literature to compare our results.</p><p>This is the first study that evaluates the bacterial composition in exposed women to known risk factors for lung diseases with normal lung function. We identified high levels of IL&#8208;1&#946; in the sputum of tobacco&#8208;smoking women. In women with biomass&#8208;burning smoke exposure exist a positive correlation between BiEx and abundance of Bacteroidota and Fusobacteriota. These changes in women exposed to environmental risk factors, despite not having lung function impairment, alter bacterial composition that contributes to inflammatory diseases such as COPD or asthma.</p></sec><sec sec-type="conclusions" id="iid3825-sec-0180"><label>5</label><title>CONCLUSIONS</title><p>Compared to biomass&#8208;burning smoke&#8208;exposed women, current smokers have poor lung function and high levels of IL&#8208;1&#946; in sputum. Women with biomass&#8208;burning smoke exposure present an increased abundance of Bacteroidota and Fusobacteriota.</p></sec><sec id="iid3825-sec-0190"><title>AUTHOR CONTRIBUTIONS</title><p>
<bold>Fernando Morales&#8208;Gonz&#225;lez</bold>: Data curation; formal analysis; methodology; software. <bold>Juan Alberto Lira&#8208;Lucio</bold>: Data curation; formal analysis; methodology; software. <bold>Ramc&#233;s Falf&#225;n&#8208;Valencia</bold>: Conceptualization; funding acquisition; investigation; writing&#8212;original draft. <bold>Jos&#233; Eduardo M&#225;rquez&#8208;Garc&#237;a</bold>: Resources; validation. <bold>Edgar Abarca&#8208;Rojano</bold>: Resources; validation; writing&#8212;review &amp; editing. <bold>Alejandra Ram&#237;rez&#8208;Venegas</bold>: Conceptualization; investigation; writing&#8212;original draft. <bold>Ra&#250;l H Sansores</bold>: Methodology; visualization. <bold>Leonor Garc&#237;a&#8208;G&#243;mez</bold>: Resources; validation. <bold>Andrea Hern&#225;ndez&#8208;P&#233;rez</bold>: Resources; validation. <bold>Gloria P&#233;rez&#8208;Rubio</bold>: Conceptualization; formal analysis; project administration; resources; software; writing&#8212;original draft.</p></sec><sec sec-type="COI-statement" id="iid3825-sec-0210"><title>CONFLICTS OF INTEREST STATEMENT</title><p>The authors declare no conflict of interest.</p></sec><sec id="iid3825-sec-0240"><title>INSTITUTIONAL REVIEW BOARD STATEMENT</title><p>The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the INER committee on bioethics and research (protocol number B01&#8208;17).</p></sec><sec id="iid3825-sec-0250"><title>INFORMED CONSENT STATEMENT</title><p>Informed consent was obtained from all subjects involved in the study.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="iid3825-suppl-0001" position="float" content-type="local-data" orientation="portrait"><caption><p>Supporting information.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="IID3-11-e825-s001.pdf" position="float" orientation="portrait"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack id="iid3825-sec-0200"><title>ACKNOWLEDGMENTS</title><p>This work is supported by the allocated budget to research (RFV&#8208;HLA Laboratory) from the Instituto Nacional de Enfermedades Respiratorias Ismael Cos&#237;o Villegas (INER).</p></ack><sec sec-type="data-availability" id="iid3825-sec-0230"><title>DATA AVAILABILITY STATEMENT</title><p>The data sets generated for this study can be found in the Sequence Read Archive (SRA). Submission: SUB9326500. Available in <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/716362" ext-link-type="uri" specific-use="software is-supplemented-by">https://www.ncbi.nlm.nih.gov/bioproject/716362</ext-link>.</p></sec><ref-list content-type="cited-references" id="iid3825-bibl-0001"><title>REFERENCES</title><ref id="iid3825-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="iid3825-cit-0001"><string-name name-style="western"><surname>Adar</surname><given-names>SD</given-names></string-name>, <string-name name-style="western"><surname>Huffnagle</surname><given-names>GB</given-names></string-name>, <string-name name-style="western"><surname>Curtis</surname><given-names>JL</given-names></string-name>. <article-title>The respiratory microbiome: an underappreciated player in the human response to inhaled pollutants?</article-title><source>Ann Epidemiol</source>. <year>2016</year>;<volume>26</volume>(<issue>5</issue>):<fpage>355</fpage>&#8208;<lpage>359</lpage>. <pub-id pub-id-type="doi">10.1016/j.annepidem.2016.03.010</pub-id><pub-id pub-id-type="pmid">27161078</pub-id><pub-id pub-id-type="pmcid">PMC4898199</pub-id></mixed-citation></ref><ref id="iid3825-bib-0002"><label>2</label><mixed-citation publication-type="journal" id="iid3825-cit-0002"><string-name name-style="western"><surname>Dickson</surname><given-names>RP</given-names></string-name>, <string-name name-style="western"><surname>Erb&#8208;Downward</surname><given-names>JR</given-names></string-name>, <string-name name-style="western"><surname>Martinez</surname><given-names>FJ</given-names></string-name>, <string-name name-style="western"><surname>Huffnagle</surname><given-names>GB</given-names></string-name>. <article-title>The microbiome and the respiratory tract</article-title>. <source>Annu Rev Physiol</source>. <year>2016</year>;<volume>78</volume>:<fpage>481</fpage>&#8208;<lpage>504</lpage>. <pub-id pub-id-type="doi">10.1146/annurev-physiol-021115-105238</pub-id><pub-id pub-id-type="pmid">26527186</pub-id><pub-id pub-id-type="pmcid">PMC4751994</pub-id></mixed-citation></ref><ref id="iid3825-bib-0003"><label>3</label><mixed-citation publication-type="journal" id="iid3825-cit-0003"><string-name name-style="western"><surname>Dickson</surname><given-names>RP</given-names></string-name>, <string-name name-style="western"><surname>Erb&#8208;Downward</surname><given-names>JR</given-names></string-name>, <string-name name-style="western"><surname>Freeman</surname><given-names>CM</given-names></string-name>, et al. <article-title>Bacterial topography of the healthy human lower respiratory tract</article-title>. <source>mBio</source>. <year>2017</year>;<volume>8</volume>(<issue>1</issue>):<fpage>e02287</fpage>&#8208;<lpage>16</lpage>. <pub-id pub-id-type="doi">10.1128/mBio.02287-16</pub-id><pub-id pub-id-type="pmid">28196961</pub-id><pub-id pub-id-type="pmcid">PMC5312084</pub-id></mixed-citation></ref><ref id="iid3825-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="iid3825-cit-0004"><string-name name-style="western"><surname>Lee</surname><given-names>SY</given-names></string-name>, <string-name name-style="western"><surname>Mac Aog&#225;in</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Fam</surname><given-names>KD</given-names></string-name>, et al. <article-title>Airway microbiome composition correlates with lung function and arterial stiffness in an age&#8208;dependent manner</article-title>. <source>PLoS One</source>. <year>2019</year>;<volume>14</volume>(<issue>11</issue>):<elocation-id>e0225636</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone</pub-id><pub-id pub-id-type="pmid">31770392</pub-id><pub-id pub-id-type="pmcid">PMC6879132</pub-id></mixed-citation></ref><ref id="iid3825-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="iid3825-cit-0005"><string-name name-style="western"><surname>Erb&#8208;Downward</surname><given-names>JR</given-names></string-name>, <string-name name-style="western"><surname>Thompson</surname><given-names>DL</given-names></string-name>, <string-name name-style="western"><surname>Han</surname><given-names>MK</given-names></string-name>, et al. <article-title>Analysis of the lung microbiome in the &#8220;healthy&#8221; smoker and in COPD</article-title>. <source>PLoS One</source>. <year>2011</year>;<volume>6</volume>(<issue>2</issue>):<elocation-id>e16384</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone.0016384</pub-id><pub-id pub-id-type="pmid">21364979</pub-id><pub-id pub-id-type="pmcid">PMC3043049</pub-id></mixed-citation></ref><ref id="iid3825-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="iid3825-cit-0006"><string-name name-style="western"><surname>Lim</surname><given-names>MY</given-names></string-name>, <string-name name-style="western"><surname>Yoon</surname><given-names>HS</given-names></string-name>, <string-name name-style="western"><surname>Rho</surname><given-names>M</given-names></string-name>, et al. <article-title>Analysis of the association between host genetics, smoking, and sputum microbiota in healthy humans</article-title>. <source>Sci Rep</source>. <year>2016</year>;<volume>6</volume>:<elocation-id>23745</elocation-id>. <pub-id pub-id-type="doi">10.1038/srep23745</pub-id><pub-id pub-id-type="pmid">27030383</pub-id><pub-id pub-id-type="pmcid">PMC4814871</pub-id></mixed-citation></ref><ref id="iid3825-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="iid3825-cit-0007"><string-name name-style="western"><surname>Steinberg</surname><given-names>MB</given-names></string-name>, <string-name name-style="western"><surname>Akincigil</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Kim</surname><given-names>EJ</given-names></string-name>, <string-name name-style="western"><surname>Shallis</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Delnevo</surname><given-names>CD</given-names></string-name>. <article-title>Tobacco smoking as a risk factor for increased antibiotic prescription</article-title>. <source>Am J Prev Med</source>. <year>2016</year>;<volume>50</volume>(<issue>6</issue>):<fpage>692</fpage>&#8208;<lpage>698</lpage>. <pub-id pub-id-type="doi">10.1016/j.amepre.2015.11.009</pub-id><pub-id pub-id-type="pmid">26702478</pub-id><pub-id pub-id-type="pmcid">PMC5189690</pub-id></mixed-citation></ref><ref id="iid3825-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="iid3825-cit-0008"><string-name name-style="western"><surname>Dicker</surname>, <given-names>AJ</given-names></string-name>, <string-name name-style="western"><surname>Huang</surname>, <given-names>JTJ</given-names></string-name>, <string-name name-style="western"><surname>Lonergan</surname>, <given-names>M</given-names></string-name>, et al. <article-title>The sputum microbiome, airway inflammation, and mortality in chronic obstructive pulmonary disease</article-title>. <source>J Allergy Clin Immunol</source>. <year>2021</year>;<volume>147</volume>(<issue>1</issue>):<fpage>158</fpage>&#8208;<lpage>167</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaci.2020.02.040</pub-id><pub-id pub-id-type="pmid">32353489</pub-id></mixed-citation></ref><ref id="iid3825-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="iid3825-cit-0009"><string-name name-style="western"><surname>Wang</surname>, <given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Locantore</surname>, <given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Haldar</surname>, <given-names>K</given-names></string-name>, et al. <article-title>Inflammatory endotype&#8208;associated airway microbiome in chronic obstructive pulmonary disease clinical stability and exacerbations: a multicohort longitudinal analysis</article-title>. <source>Am J Respir Crit Care Med</source>. <year>2021</year>;<volume>203</volume>(<issue>12</issue>):<fpage>1488</fpage>&#8208;<lpage>1502</lpage>. <pub-id pub-id-type="doi">10.1164/rccm.202009-3448OC</pub-id><pub-id pub-id-type="pmid">33332995</pub-id><pub-id pub-id-type="pmcid">PMC8483235</pub-id></mixed-citation></ref><ref id="iid3825-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="iid3825-cit-0010"><string-name name-style="western"><surname>Yang</surname><given-names>CY</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>SW</given-names></string-name>, <string-name name-style="western"><surname>Chin</surname><given-names>CY</given-names></string-name>, et al. <article-title>Association of exacerbation phenotype with the sputum microbiome in chronic obstructive pulmonary disease patients during the clinically stable state</article-title>. <source>J Transl Med</source>. <year>2021</year>;<volume>19</volume>(<issue>1</issue>):<fpage>121</fpage>. <pub-id pub-id-type="doi">10.1186/s12967-021-02788-4</pub-id><pub-id pub-id-type="pmid">33757530</pub-id><pub-id pub-id-type="pmcid">PMC7988976</pub-id></mixed-citation></ref><ref id="iid3825-bib-0011"><label>11</label><mixed-citation publication-type="journal" id="iid3825-cit-0011"><string-name name-style="western"><surname>M&#246;ller</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Heimbeck</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Hofer</surname><given-names>TPJ</given-names></string-name>, et al. <article-title>Differential inflammatory response to inhaled lipopolysaccharide targeted either to the airways or the alveoli in man</article-title>. <source>PLoS One</source>. <year>2012</year>;<volume>7</volume>(<issue>4</issue>):<elocation-id>e33505</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone.0033505</pub-id><pub-id pub-id-type="pmid">22496751</pub-id><pub-id pub-id-type="pmcid">PMC3319549</pub-id></mixed-citation></ref><ref id="iid3825-bib-0012"><label>12</label><mixed-citation publication-type="miscellaneous" id="iid3825-cit-0012"><collab collab-type="authors">World Health Organization</collab>
. Indoor air pollution and household energy, Health, and environment impacts [Internet]. Accessed December, <year>2020</year>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.who.int/heli/risks/indoorair/indoorair/en/" ext-link-type="uri">https://www.who.int/heli/risks/indoorair/indoorair/en/</ext-link></mixed-citation></ref><ref id="iid3825-bib-0013"><label>13</label><mixed-citation publication-type="journal" id="iid3825-cit-0013"><string-name name-style="western"><surname>Regalado</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>P&#233;rez&#8208;Padilla</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Sansores</surname><given-names>R</given-names></string-name>, et al. <article-title>The effect of biomass burning on respiratory symptoms and lung function in rural Mexican women</article-title>. <source>Am J Respir Crit Care Med</source>. <year>2006</year>;<volume>174</volume>(<issue>8</issue>):<fpage>901</fpage>&#8208;<lpage>905</lpage>. <pub-id pub-id-type="doi">10.1164/rccm.200503-479OC</pub-id><pub-id pub-id-type="pmid">16799080</pub-id></mixed-citation></ref><ref id="iid3825-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="iid3825-cit-0014"><string-name name-style="western"><surname>Salvi</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Barnes</surname><given-names>PJ.</given-names></string-name><article-title>Is exposure to biomass smoke the biggest risk factor for COPD globally?</article-title><source>Chest</source>. <year>2010</year>;<volume>138</volume>(<issue>1</issue>):<fpage>3</fpage>&#8208;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1378/chest.10-0645</pub-id><pub-id pub-id-type="pmid">20605806</pub-id></mixed-citation></ref><ref id="iid3825-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="iid3825-cit-0015"><string-name name-style="western"><surname>Kurmi</surname><given-names>OP</given-names></string-name>, <string-name name-style="western"><surname>Semple</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Devereux</surname><given-names>GS</given-names></string-name>, et al. <article-title>The effect of exposure to biomass smoke on respiratory symptoms in adult rural and urban Nepalese populations</article-title>. <source>Environ Health</source>. <year>2014</year>;<volume>13</volume>:<elocation-id>92</elocation-id>. <pub-id pub-id-type="doi">10.1186/1476-069X-13-92</pub-id><pub-id pub-id-type="pmid">25374400</pub-id><pub-id pub-id-type="pmcid">PMC4232609</pub-id></mixed-citation></ref><ref id="iid3825-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="iid3825-cit-0016"><string-name name-style="western"><surname>Wang</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Cheng</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>D</given-names></string-name>, et al. <article-title>Airway microbiome is associated with respiratory functions and responses to ambient particulate matter exposure</article-title>. <source>Ecotoxicol Environ Safety</source>. <year>2019</year>;<volume>167</volume>:<fpage>269</fpage>&#8208;<lpage>277</lpage>. <pub-id pub-id-type="doi">10.1016/j.ecoenv.2018.09.079</pub-id><pub-id pub-id-type="pmid">30342360</pub-id><pub-id pub-id-type="pmcid">PMC6257984</pub-id></mixed-citation></ref><ref id="iid3825-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="iid3825-cit-0017"><string-name name-style="western"><surname>Rylance</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Kankwatira</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Nelson</surname><given-names>DE</given-names></string-name>, et al. <article-title>Household air pollution and the lung microbiome of healthy adults in Malawi: a cross&#8208;sectional study</article-title>. <source>BMC Microbiol</source>. <year>2016</year>;<volume>16</volume>(<issue>1</issue>):<fpage>182</fpage>. <pub-id pub-id-type="doi">10.1186/s12866-016-0803-7</pub-id><pub-id pub-id-type="pmid">27514621</pub-id><pub-id pub-id-type="pmcid">PMC4982214</pub-id></mixed-citation></ref><ref id="iid3825-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="iid3825-cit-0018"><string-name name-style="western"><surname>Rogers</surname><given-names>GB</given-names></string-name>, <string-name name-style="western"><surname>Wesselingh</surname><given-names>S</given-names></string-name>. <article-title>Precision respiratory medicine and the microbiome</article-title>. <source>Lancet Respir Med</source>. <year>2016</year>;<volume>4</volume>(<issue>1</issue>):<fpage>73</fpage>&#8208;<lpage>82</lpage>. <pub-id pub-id-type="doi">10.1016/S2213-2600(15)00476-2</pub-id><pub-id pub-id-type="pmid">26700443</pub-id></mixed-citation></ref><ref id="iid3825-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="iid3825-cit-0019"><string-name name-style="western"><surname>Brakema</surname><given-names>EA</given-names></string-name>, <string-name name-style="western"><surname>van Gemert</surname><given-names>FA</given-names></string-name>, <string-name name-style="western"><surname>van der Kleij</surname><given-names>RMJJ</given-names></string-name>, et al. <article-title>COPD's early origins in low&#8208;and&#8208;middle income countries: what are the implications of a false start?</article-title><source>NPJ Prim Care Respir Med</source>. <year>2019</year>;<volume>29</volume>(<issue>1</issue>):<fpage>6</fpage>.<pub-id pub-id-type="pmid">30837469</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41533-019-0117-y</pub-id><pub-id pub-id-type="pmcid">PMC6401185</pub-id></mixed-citation></ref><ref id="iid3825-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="iid3825-cit-0020"><string-name name-style="western"><surname>P&#233;rez&#8208;Padilla</surname><given-names>JR</given-names></string-name>, <string-name name-style="western"><surname>Regalado&#8208;Pineda</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>V&#225;zquez&#8208;Garc&#237;a</surname><given-names>JC</given-names></string-name>. <article-title>Reproducibilidad de espirometr&#237;as en trabajadores mexicanos y valores de referencia internacionales [Reproducibility of spirometry in Mexican workers and internacional reference values]</article-title>. <source>Salud Publica Mex</source>. <year>2001</year>;<volume>43</volume>(<issue>2</issue>):<fpage>113</fpage>&#8208;<lpage>121</lpage>.<pub-id pub-id-type="pmid">11381840</pub-id></mixed-citation></ref><ref id="iid3825-bib-0021"><label>21</label><mixed-citation publication-type="miscellaneous" id="iid3825-cit-0021"><collab collab-type="authors">National Institute for Occupational Safety and Health, Department of Health and Human Services, Public Health Service, Centers for Disease Control</collab>
. NIOSH Manual of Spirometry in Occupational Medicine. [Internet]. <year>1981</year>. Accessed December 18, 2020. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.cdc.gov/niosh/docs/2004-154c/" ext-link-type="uri">https://www.cdc.gov/niosh/docs/2004-154c/</ext-link></mixed-citation></ref><ref id="iid3825-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="iid3825-cit-0022"><string-name name-style="western"><surname>Chanez</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Holz</surname><given-names>O</given-names></string-name>, <string-name name-style="western"><surname>Ind</surname><given-names>PW</given-names></string-name>, <string-name name-style="western"><surname>Djukanovic</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Maestrelli</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Sterk</surname><given-names>PJ</given-names></string-name>. <article-title>Sputum induction</article-title>. <source>Eur Respir J</source>. <year>2002</year>;<volume>20</volume>:<fpage>3S</fpage>&#8208;<lpage>8s</lpage>. <pub-id pub-id-type="doi">10.1183/09031936.02.00000302</pub-id><pub-id pub-id-type="pmid">12361361</pub-id></mixed-citation></ref><ref id="iid3825-bib-0023"><label>23</label><mixed-citation publication-type="miscellaneous" id="iid3825-cit-0023"><collab collab-type="authors">RStudio Team</collab>
. RStudio: integrated development for R. RStudio. <year>2015</year>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://rstudio.com/products/rstudio/" ext-link-type="uri">https://rstudio.com/products/rstudio/</ext-link></mixed-citation></ref><ref id="iid3825-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="iid3825-cit-0024"><string-name name-style="western"><surname>Callahan</surname><given-names>BJ</given-names></string-name>, <string-name name-style="western"><surname>McMurdie</surname><given-names>PJ</given-names></string-name>, <string-name name-style="western"><surname>Rosen</surname><given-names>MJ</given-names></string-name>, <string-name name-style="western"><surname>Han</surname><given-names>AW</given-names></string-name>, <string-name name-style="western"><surname>Johnson</surname><given-names>AJA</given-names></string-name>, <string-name name-style="western"><surname>Holmes</surname><given-names>SP</given-names></string-name>. <article-title>DADA2: high&#8208;resolution sample inference from Illumina amplicon data</article-title>. <source>Nature Methods</source>. <year>2016</year>;<volume>13</volume>(<issue>7</issue>):<fpage>581</fpage>&#8208;<lpage>583</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth.3869</pub-id><pub-id pub-id-type="pmid">27214047</pub-id><pub-id pub-id-type="pmcid">PMC4927377</pub-id></mixed-citation></ref><ref id="iid3825-bib-0025"><label>25</label><mixed-citation publication-type="journal" id="iid3825-cit-0025"><string-name name-style="western"><surname>McMurdie</surname><given-names>PJ</given-names></string-name>, <string-name name-style="western"><surname>Holmes</surname><given-names>S</given-names></string-name>. <article-title>phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data</article-title>. <source>PLoS One</source>. <year>2013</year>;<volume>8</volume>(<issue>4</issue>):<elocation-id>e61217</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone.0061217</pub-id><pub-id pub-id-type="pmid">23630581</pub-id><pub-id pub-id-type="pmcid">PMC3632530</pub-id></mixed-citation></ref><ref id="iid3825-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="iid3825-cit-0026"><string-name name-style="western"><surname>Love</surname><given-names>MI</given-names></string-name>, <string-name name-style="western"><surname>Huber</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Anders</surname><given-names>S</given-names></string-name>. <article-title>Moderated estimation of fold change and dispersion for RNA&#8208;seq data with DESeq. 2</article-title>. <source>Genome Biol</source>. <year>2014</year>;<volume>15</volume>(<issue>12</issue>):<fpage>550</fpage>. <pub-id pub-id-type="doi">10.1186/s13059-014-0550-8</pub-id><pub-id pub-id-type="pmid">25516281</pub-id><pub-id pub-id-type="pmcid">PMC4302049</pub-id></mixed-citation></ref><ref id="iid3825-bib-0027"><label>27</label><mixed-citation publication-type="book" id="iid3825-cit-0027"><string-name name-style="western"><surname>Wickham</surname><given-names>H</given-names></string-name>. <source>ggplot2: Elegant Graphics for Data Analysis</source>. <publisher-name>Springer&#8208;Verlag</publisher-name>; <year>2016</year>.</mixed-citation></ref><ref id="iid3825-bib-0028"><label>28</label><mixed-citation publication-type="miscellaneous" id="iid3825-cit-0028"><string-name name-style="western"><surname>Lathi</surname><given-names>L</given-names></string-name>, <string-name name-style="western"><surname>Shetty</surname><given-names>S.</given-names></string-name> Tools for microbiome analysis in R. Versionversion 2.1.24. Bioconductor.&#160; <year>2017</year>.</mixed-citation></ref><ref id="iid3825-bib-0029"><label>29</label><mixed-citation publication-type="journal" id="iid3825-cit-0029"><string-name name-style="western"><surname>Callahan</surname><given-names>BJ</given-names></string-name>, <string-name name-style="western"><surname>Sankaran</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Fukuyama</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>McMurdie</surname><given-names>PJ</given-names></string-name>, <string-name name-style="western"><surname>Holmes</surname><given-names>SP</given-names></string-name>. <article-title>Bioconductor workflow for microbiome data analysis: from raw reads to community analyses</article-title>. <source>F1000Res</source>. <year>2016b</year>;<volume>5</volume>:<fpage>1492</fpage>. <pub-id pub-id-type="doi">10.12688/f1000research.8986.2</pub-id><pub-id pub-id-type="pmid">27508062</pub-id><pub-id pub-id-type="pmcid">PMC4955027</pub-id></mixed-citation></ref><ref id="iid3825-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="iid3825-cit-0030"><string-name name-style="western"><surname>Quast</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Pruesse</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Yilmaz</surname><given-names>P</given-names></string-name>, et al. <article-title>The SILVA ribosomal RNA gene database project: improved data processing and web&#8208;based tools</article-title>. <source>Nucleic Acids Res</source>. <year>2012</year>;<volume>41</volume>(<issue>Database issue</issue>):<fpage>D590</fpage>&#8208;<lpage>D596</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gks1219</pub-id><pub-id pub-id-type="pmid">23193283</pub-id><pub-id pub-id-type="pmcid">PMC3531112</pub-id></mixed-citation></ref><ref id="iid3825-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="iid3825-cit-0031"><string-name name-style="western"><surname>Weiss</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Xu</surname><given-names>ZZ</given-names></string-name>, <string-name name-style="western"><surname>Peddada</surname><given-names>S</given-names></string-name>, et al. <article-title>Normalization and microbial differential abundance strategies depend upon data characteristics</article-title>. <source>Microbiome</source>. <year>2017</year>;<volume>5</volume>(<issue>1</issue>):<fpage>27</fpage>. <pub-id pub-id-type="doi">10.1186/s40168-017-0237-y</pub-id><pub-id pub-id-type="pmid">28253908</pub-id><pub-id pub-id-type="pmcid">PMC5335496</pub-id></mixed-citation></ref><ref id="iid3825-bib-0032"><label>32</label><mixed-citation publication-type="miscellaneous" id="iid3825-cit-0032"><string-name name-style="western"><surname>Wei</surname><given-names>T</given-names></string-name>. Package&#8216;corrplot&#8217;. <year>2013</year>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://github.com/taiyun/corrplot" ext-link-type="uri">https://github.com/taiyun/corrplot</ext-link></mixed-citation></ref><ref id="iid3825-bib-0033"><label>33</label><mixed-citation publication-type="miscellaneous" id="iid3825-cit-0033"><collab collab-type="authors">Global Initiative for Chronic Obstructive Lung Disease</collab>
. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Global Initiative for Chronic Obstructive Lung Disease; <year>2020</year>. <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://www.goldcopd.org/" ext-link-type="uri">http://www.goldcopd.org/</ext-link></mixed-citation></ref><ref id="iid3825-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="iid3825-cit-0034"><string-name name-style="western"><surname>Oelsner</surname><given-names>EC</given-names></string-name>, <string-name name-style="western"><surname>Balte</surname><given-names>PP</given-names></string-name>, <string-name name-style="western"><surname>Bhatt</surname><given-names>SP</given-names></string-name>, et al. <article-title>Lung function decline in former smokers and low&#8208;intensity current smokers: a secondary data analysis of the NHLBI pooled cohorts study</article-title>. <source>Lancet Respir Med</source>. <year>2020</year>;<volume>8</volume>(<issue>1</issue>):<fpage>34</fpage>&#8208;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1016/S2213-2600(19)30276-0</pub-id><pub-id pub-id-type="pmid">31606435</pub-id><pub-id pub-id-type="pmcid">PMC7261004</pub-id></mixed-citation></ref><ref id="iid3825-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="iid3825-cit-0035"><string-name name-style="western"><surname>Shiels</surname><given-names>MS</given-names></string-name>, <string-name name-style="western"><surname>Katki</surname><given-names>HA</given-names></string-name>, <string-name name-style="western"><surname>Freedman</surname><given-names>ND</given-names></string-name>, et al. <article-title>Cigarette smoking and variations in systemic immune and inflammation markers</article-title>. <source>JNCI</source>. <year>2014</year>;<volume>106</volume>(<issue>11</issue>):<elocation-id>dju294</elocation-id>. <pub-id pub-id-type="doi">10.1093/jnci/dju294</pub-id><pub-id pub-id-type="pmid">25274579</pub-id><pub-id pub-id-type="pmcid">PMC4200029</pub-id></mixed-citation></ref><ref id="iid3825-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="iid3825-cit-0036"><string-name name-style="western"><surname>Ram&#237;rez&#8208;Venegas</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Sansores</surname><given-names>RH</given-names></string-name>, <string-name name-style="western"><surname>P&#233;rez&#8208;Padilla</surname><given-names>R</given-names></string-name>, et al. <article-title>Survival of patients with chronic obstructive pulmonary disease due to biomass smoke and tobacco</article-title>. <source>Am J Respir Crit Care Med</source>. <year>2006</year>;<volume>173</volume>(<issue>4</issue>):<fpage>393</fpage>&#8208;<lpage>397</lpage>. <pub-id pub-id-type="doi">10.1164/rccm.200504-568OC</pub-id><pub-id pub-id-type="pmid">16322646</pub-id></mixed-citation></ref><ref id="iid3825-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="iid3825-cit-0037"><string-name name-style="western"><surname>P&#233;rez&#8208;Padilla</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Ramirez&#8208;Venegas</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Sansores&#8208;Martinez</surname><given-names>R</given-names></string-name>. <article-title>Clinical characteristics of patients with biomass smoke&#8208;associated COPD and chronic bronchitis, 2004&#8208;2014</article-title>. <source>Chronic Obstr Pulm Dis</source>. <year>2014</year>;<volume>1</volume>(<issue>1</issue>):<fpage>23</fpage>&#8208;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.15326/jcopdf.1.1.2013.0004</pub-id><pub-id pub-id-type="pmid">28848808</pub-id><pub-id pub-id-type="pmcid">PMC5559138</pub-id></mixed-citation></ref><ref id="iid3825-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="iid3825-cit-0038"><string-name name-style="western"><surname>Ram&#237;rez&#8208;Venegas</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Sansores</surname><given-names>RH</given-names></string-name>, <string-name name-style="western"><surname>Quintana&#8208;Carrillo</surname><given-names>RH</given-names></string-name>, et al. <article-title>FEV1 decline in patients with chronic obstructive pulmonary disease associated with biomass exposure</article-title>. <source>Am J Respir Crit Care Med</source>. <year>2014</year>;<volume>190</volume>(<issue>9</issue>):<fpage>996</fpage>&#8208;<lpage>1002</lpage>. <pub-id pub-id-type="doi">10.1164/rccm.201404-0720OC</pub-id><pub-id pub-id-type="pmid">25172140</pub-id></mixed-citation></ref><ref id="iid3825-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="iid3825-cit-0039"><string-name name-style="western"><surname>Charlson</surname><given-names>ES</given-names></string-name>, <string-name name-style="western"><surname>Bittinger</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Haas</surname><given-names>AR</given-names></string-name>, et al. <article-title>Topographical continuity of bacterial populations in the healthy human respiratory tract</article-title>. <source>Am J Respir Crit Care Med</source>. <year>2011</year>;<volume>184</volume>(<issue>8</issue>):<fpage>957</fpage>&#8208;<lpage>963</lpage>. <pub-id pub-id-type="doi">10.1164/rccm.201104-0655OC</pub-id><pub-id pub-id-type="pmid">21680950</pub-id><pub-id pub-id-type="pmcid">PMC3208663</pub-id></mixed-citation></ref><ref id="iid3825-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="iid3825-cit-0040"><string-name name-style="western"><surname>Garzoni</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Brugger</surname><given-names>SD</given-names></string-name>, <string-name name-style="western"><surname>Qi</surname><given-names>W</given-names></string-name>, et al. <article-title>Microbial communities in the respiratory tract of patients with interstitial lung disease</article-title>. <source>Thorax</source>. <year>2013</year>;<volume>68</volume>(<issue>12</issue>):<fpage>1150</fpage>&#8208;<lpage>1156</lpage>. <pub-id pub-id-type="doi">10.1136/thoraxjnl-2012-202917</pub-id><pub-id pub-id-type="pmid">23945167</pub-id><pub-id pub-id-type="pmcid">PMC3841796</pub-id></mixed-citation></ref><ref id="iid3825-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="iid3825-cit-0041"><string-name name-style="western"><surname>Zhang</surname><given-names>Q</given-names></string-name>, <string-name name-style="western"><surname>Cox</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Liang</surname><given-names>Z</given-names></string-name>, et al. <article-title>Airway microbiota in severe asthma and relationship to asthma severity and phenotypes</article-title>. <source>PLoS One</source>. <year>2016</year>;<volume>11</volume>(<issue>4</issue>):<elocation-id>e0152724</elocation-id>.<pub-id pub-id-type="pmid">27078029</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0152724</pub-id><pub-id pub-id-type="pmcid">PMC4831690</pub-id></mixed-citation></ref><ref id="iid3825-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="iid3825-cit-0042"><string-name name-style="western"><surname>Hellermann</surname><given-names>GR</given-names></string-name>, <string-name name-style="western"><surname>Nagy</surname><given-names>SB</given-names></string-name>, <string-name name-style="western"><surname>Kong</surname><given-names>X</given-names></string-name>, <string-name name-style="western"><surname>Lockey</surname><given-names>RF</given-names></string-name>, <string-name name-style="western"><surname>Mohapatra</surname><given-names>SS</given-names></string-name>. <article-title>Mechanism of cigarette smoke condensate&#8208;induced acute inflammatory response in human bronchial epithelial cells</article-title>. <source>Respir Res</source>. <year>2002</year>;<volume>3</volume>(<issue>1</issue>):<fpage>15</fpage>. <pub-id pub-id-type="doi">10.1186/rr172</pub-id><pub-id pub-id-type="pmid">12204101</pub-id><pub-id pub-id-type="pmcid">PMC150508</pub-id></mixed-citation></ref><ref id="iid3825-bib-0043"><label>43</label><mixed-citation publication-type="journal" id="iid3825-cit-0043"><string-name name-style="western"><surname>Yi</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Liang</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>M</given-names></string-name>, et al. <article-title>A large lung gene expression study identifying IL1B as a novel player in airway inflammation in COPD airway epithelial cells</article-title>. <source>Inflamm Res</source>. <year>2018</year>;<volume>67</volume>(<issue>6</issue>):<fpage>539</fpage>&#8208;<lpage>551</lpage>. <pub-id pub-id-type="doi">10.1007/s00011-018-1145-8</pub-id><pub-id pub-id-type="pmid">29616282</pub-id></mixed-citation></ref><ref id="iid3825-bib-0044"><label>44</label><mixed-citation publication-type="journal" id="iid3825-cit-0044"><string-name name-style="western"><surname>Damera</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Pham</surname><given-names>TH</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>J</given-names></string-name>, et al. <article-title>A sputum proteomic signature that associates with increased IL&#8208;1&#946; levels and bacterial exacerbations of COPD</article-title>. <source>Lung</source>. <year>2016</year>;<volume>194</volume>(<issue>3</issue>):<fpage>363</fpage>&#8208;<lpage>369</lpage>. <pub-id pub-id-type="doi">10.1007/s00408-016-9877-0</pub-id><pub-id pub-id-type="pmid">27083436</pub-id></mixed-citation></ref><ref id="iid3825-bib-0045"><label>45</label><mixed-citation publication-type="journal" id="iid3825-cit-0045"><string-name name-style="western"><surname>Fu</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>McDonald</surname><given-names>VM</given-names></string-name>, <string-name name-style="western"><surname>Baines</surname><given-names>KJ</given-names></string-name>, <string-name name-style="western"><surname>Gibson</surname><given-names>PG</given-names></string-name>. <article-title>Airway IL&#8208;1&#946; and systemic inflammation as predictors of future exacerbation risk in asthma and COPD</article-title>. <source>Chest</source>. <year>2015</year>;<volume>148</volume>(<issue>3</issue>):<fpage>618</fpage>&#8208;<lpage>629</lpage>. <pub-id pub-id-type="doi">10.1378/chest.14-2337</pub-id><pub-id pub-id-type="pmid">25950204</pub-id></mixed-citation></ref><ref id="iid3825-bib-0046"><label>46</label><mixed-citation publication-type="journal" id="iid3825-cit-0046"><string-name name-style="western"><surname>Larsen</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Musavian</surname><given-names>HS</given-names></string-name>, <string-name name-style="western"><surname>Butt</surname><given-names>TM</given-names></string-name>, <string-name name-style="western"><surname>Ingvorsen</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Thysen</surname><given-names>AH</given-names></string-name>, <string-name name-style="western"><surname>Brix</surname><given-names>S</given-names></string-name>. <article-title>Chronic obstructive pulmonary disease and asthma&#8208;associated Proteobacteria, but not commensal <italic toggle="yes">Prevotella</italic> spp., promote toll&#8208;like receptor 2&#8208;independent lung inflammation and pathology</article-title>. <source>Immunology</source>. <year>2015</year>;<volume>144</volume>(<issue>2</issue>):<fpage>333</fpage>&#8208;<lpage>342</lpage>. <pub-id pub-id-type="doi">10.1111/imm.12376</pub-id><pub-id pub-id-type="pmid">25179236</pub-id><pub-id pub-id-type="pmcid">PMC4298427</pub-id></mixed-citation></ref><ref id="iid3825-bib-0047"><label>47</label><mixed-citation publication-type="journal" id="iid3825-cit-0047"><string-name name-style="western"><surname>Harrandah</surname><given-names>AM</given-names></string-name>, <string-name name-style="western"><surname>Chukkapalli</surname><given-names>SS</given-names></string-name>, <string-name name-style="western"><surname>Bhattacharyya</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Progulske&#8208;Fox</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Chan</surname><given-names>EKL</given-names></string-name>. <article-title>Fusobacteria modulate oral carcinogenesis and promote cancer progression</article-title>. <source>J Oral Microbiol</source>. <year>2020</year>;<volume>13</volume>(<issue>1</issue>):<elocation-id>1849493</elocation-id>. <pub-id pub-id-type="doi">10.1080/20002297.2020.1849493</pub-id><pub-id pub-id-type="pmid">33391626</pub-id><pub-id pub-id-type="pmcid">PMC7717872</pub-id></mixed-citation></ref><ref id="iid3825-bib-0048"><label>48</label><mixed-citation publication-type="journal" id="iid3825-cit-0048"><string-name name-style="western"><surname>Hilty</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Burke</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Pedro</surname><given-names>H</given-names></string-name>, et al. <article-title>Disordered microbial communities in asthmatic airways</article-title>. <source>PLoS One</source>. <year>2010</year>;<volume>5</volume>(<issue>1</issue>):<elocation-id>e8578</elocation-id>. <pub-id pub-id-type="doi">10.1371/journal.pone.0008578</pub-id><pub-id pub-id-type="pmid">20052417</pub-id><pub-id pub-id-type="pmcid">PMC2798952</pub-id></mixed-citation></ref><ref id="iid3825-bib-0049"><label>49</label><mixed-citation publication-type="journal" id="iid3825-cit-0049"><string-name name-style="western"><surname>Caverly</surname><given-names>LJ</given-names></string-name>, <string-name name-style="western"><surname>Huang</surname><given-names>YJ</given-names></string-name>, <string-name name-style="western"><surname>Sze</surname><given-names>MA</given-names></string-name>. <article-title>Past, present, and future research on the lung microbiome in inflammatory airway disease</article-title>. <source>Chest</source>. <year>2019</year>;<volume>156</volume>(<issue>2</issue>):<fpage>376</fpage>&#8208;<lpage>382</lpage>. <pub-id pub-id-type="doi">10.1016/j.chest.2019.05.011</pub-id><pub-id pub-id-type="pmid">31154042</pub-id><pub-id pub-id-type="pmcid">PMC6945648</pub-id></mixed-citation></ref><ref id="iid3825-bib-0050"><label>50</label><mixed-citation publication-type="journal" id="iid3825-cit-0050"><string-name name-style="western"><surname>Ghebre</surname><given-names>MA</given-names></string-name>, <string-name name-style="western"><surname>Pang</surname><given-names>PH</given-names></string-name>, <string-name name-style="western"><surname>Diver</surname><given-names>S</given-names></string-name>, et al. <article-title>Biological exacerbation clusters demonstrate asthma and chronic obstructive pulmonary disease overlap with distinct mediator and microbiome profiles</article-title>. <source>J Allergy Clin Immunol</source>. <year>2018</year>;<volume>141</volume>(<issue>6</issue>):<fpage>2027</fpage>&#8208;<lpage>2036</lpage>. <pub-id pub-id-type="doi">10.1016/j.jaci.2018.04.013</pub-id><pub-id pub-id-type="pmid">29709671</pub-id><pub-id pub-id-type="pmcid">PMC5986707</pub-id></mixed-citation></ref><ref id="iid3825-bib-0051"><label>51</label><mixed-citation publication-type="journal" id="iid3825-cit-0051"><string-name name-style="western"><surname>Chiu</surname><given-names>YC</given-names></string-name>, <string-name name-style="western"><surname>Lee</surname><given-names>SW</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>CW</given-names></string-name>, <string-name name-style="western"><surname>Lan</surname><given-names>TY</given-names></string-name>, <string-name name-style="western"><surname>Wu</surname><given-names>LSH.</given-names></string-name><article-title>Relationship between gut microbiota and lung function decline in patients with chronic obstructive pulmonary disease: a 1&#8208;year follow&#8208;up study</article-title>. <source>Respir Res</source>. <year>2022</year>;<volume>23</volume>(<issue>1</issue>):<fpage>10</fpage>. <pub-id pub-id-type="doi">10.1186/s12931-022-01928-8</pub-id><pub-id pub-id-type="pmid">35033061</pub-id><pub-id pub-id-type="pmcid">PMC8760664</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>